94 related articles for article (PubMed ID: 10231600)
1. Proteolytic enzymes in human leukemic lymphoid cells. III. Aminopeptidases, angiotensin-converting enzyme, and its inhibitor in cells of different immunological phenotype.
Lokshina LA; Gureeva TA; Elisseeva YE; Golubeva NV; Kugaevskaya EV; Lubkova ON; Samojlova RS
Biochemistry (Mosc); 1999 Apr; 64(4):448-55. PubMed ID: 10231600
[TBL] [Abstract][Full Text] [Related]
2. Dipeptidylpeptidase IV in human leukemic B- and T-cells.
Bylinkina VS; Lokshina LA; Samojlova RS; Lubkova ON; Gureeva TA; Golubeva NV
Biochem Int; 1992 Oct; 28(1):31-9. PubMed ID: 1359891
[TBL] [Abstract][Full Text] [Related]
3. [Aminopeptidases in human leukemia cells].
Gureeva TA; Golubeva NV; Lubkova ON
Vopr Med Khim; 1999; 45(4):309-13. PubMed ID: 10547880
[TBL] [Abstract][Full Text] [Related]
4. [Proteolytic enzymes in human lymphocytic leukemia cells. II. Comparative characteristics of proteolytic enzymes and their inhibitors in three differing types of lymphoid cells].
Gureeva TA; Golubeva NV; Bylinkina VS; Lokshina LA; Pozdnev VF
Biokhimiia; 1993 Jul; 58(7):1116-25. PubMed ID: 8364126
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide degrading enzymes in normal and inflamed human synovium.
Walsh DA; Mapp PI; Wharton J; Polak JM; Blake DR
Am J Pathol; 1993 May; 142(5):1610-21. PubMed ID: 8098586
[TBL] [Abstract][Full Text] [Related]
6. [Protein kinase activity in lymphoid cells in various forms of lymphoproliferative disorders].
Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
Vopr Med Khim; 1991; 37(6):30-3. PubMed ID: 1687494
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin I-converting enzyme inhibitor peptides derived from the endostatin-containing NC1 fragment of human collagen XVIII.
Farias SL; Sabatini RA; Sampaio TC; Hirata IY; Cezari MH; Juliano MA; Sturrock ED; Carmona AK; Juliano L
Biol Chem; 2006 May; 387(5):611-6. PubMed ID: 16740133
[TBL] [Abstract][Full Text] [Related]
8. Proteolytic activities in plasma membrane preparations from rat liver. 2. Partial purification and characterization of membrane bound endopeptidases, dipeptidyl-aminopeptidase IV and aminopeptidase.
Schön E
Biomed Biochim Acta; 1983; 42(5):451-64. PubMed ID: 6360164
[TBL] [Abstract][Full Text] [Related]
9. Procyanidin structure defines the extent and specificity of angiotensin I converting enzyme inhibition.
Ottaviani JI; Actis-Goretta L; Villordo JJ; Fraga CG
Biochimie; 2006; 88(3-4):359-65. PubMed ID: 16330143
[TBL] [Abstract][Full Text] [Related]
10. Aminopeptidases and angiotensin I-converting enzyme activities in primary human lung tumors and lung parenchyma.
Procházka J; Krepela E; Sedo A; Viklický J; Fiala P
Neoplasma; 1991; 38(5):501-8. PubMed ID: 1683470
[TBL] [Abstract][Full Text] [Related]
11. Dexamethasone induced enhanced enkephalin degradation by angiotensin-converting enzyme (ACE) of endothelial cells.
Melzig MF; Heder G
Pharmazie; 1995 Feb; 50(2):139-41. PubMed ID: 7700968
[TBL] [Abstract][Full Text] [Related]
12. Activity of some proteinases and glycosidases in human leukemic lymphoid cells at various stages of differentiation.
Lokshina LA; Preobrazhenskaya ME; Samojlova RS; Bylinkina VS; Ushakova NA; Gureeva TA; Golubeva NV
Biochem Int; 1991 May; 24(1):97-106. PubMed ID: 1768266
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
14. The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells.
Laggner H; Hermann M; Esterbauer H; Muellner MK; Exner M; Gmeiner BM; Kapiotis S
J Hypertens; 2007 Oct; 25(10):2100-4. PubMed ID: 17885553
[TBL] [Abstract][Full Text] [Related]
15. The physiological significance of the alternative pathways of angiotensin II production.
Kramkowski K; Mogielnicki A; Buczko W
J Physiol Pharmacol; 2006 Dec; 57(4):529-39. PubMed ID: 17229979
[TBL] [Abstract][Full Text] [Related]
16. Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissues: effects of angiotensin I-converting enzyme inhibition and inflammation.
Moreau ME; Dubreuil P; Molinaro G; Chagnon M; Müller-Esterl W; Lepage Y; Marceau F; Adam A
J Pharmacol Exp Ther; 2005 Dec; 315(3):1065-74. PubMed ID: 16166273
[TBL] [Abstract][Full Text] [Related]
17. Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA.
Kohlstedt K; Kellner R; Busse R; Fleming I
Mol Pharmacol; 2006 Jan; 69(1):19-26. PubMed ID: 16186248
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme, enkephalinase A and aminopeptidases in the breakdown of enkephalin--studies in cell cultures.
Lentzen H; Reinsch I; Linke J
Clin Exp Hypertens A; 1984; 6(10-11):1829-32. PubMed ID: 6099767
[TBL] [Abstract][Full Text] [Related]
19. ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?
Danser AH; Batenburg WW; van den Meiracker AH; Danilov SM
Pharmacol Ther; 2007 Mar; 113(3):607-18. PubMed ID: 17257685
[TBL] [Abstract][Full Text] [Related]
20. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
Shalaby SM; Zakora M; Otte J
J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
